Morgan Stanley Gives a Buy Rating to Metlife (MET)
TipRanks (Mon, 5-Oct 8:37 AM ET)
TipRanks (Mon, 5-Oct 7:41 AM ET)
Analysts Conflicted on These Financial Names: Citigroup (C) and Metlife (MET)
TipRanks (Fri, 2-Oct 10:20 AM ET)
Jefferies Reaffirms Their Buy Rating on Metlife (MET)
TipRanks (Thu, 1-Oct 10:26 AM ET)
MetLife Investment Management Closes Galaxy 38 CLO
Business Wire (Wed, 16-Sep 8:30 AM ET)
MetLife CEO and CFO to Speak at the 2026 KBW Insurance Conference
Business Wire (Wed, 26-Aug 4:15 PM ET)
MetLife Declares Third Quarter 2026 Preferred Stock Dividends
Business Wire (Mon, 17-Aug 4:15 PM ET)
Business Wire (Tue, 11-Aug 9:00 AM ET)
MetLife Pet Insurance Winner Of 2026 Pet Innovation Award For 'Pet Insurance of the Year'
Globe Newswire (Thu, 6-Aug 8:00 AM ET)
MetLife Announces New $3 Billion Share Repurchase Authorization
Business Wire (Wed, 5-Aug 4:30 PM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of October 5, 2026, MET stock price climbed to $96.88 with 4,161,637 million shares trading.
MET has a beta of 0.77, meaning it tends to be less sensitive to market movements. MET has a correlation of 0.17 to the broad based SPY ETF.
MET has a market cap of $61.57 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $19 billion in Revenue and $2.43 earnings per share. This fell short of revenue expectation by $-563 million and exceeded earnings estimates by $.06.
In the last 3 years, MET traded as high as $100.93 and as low as $57.91.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has outperformed the market in the last year with a return of +22.0%, while the SPY ETF gained +16.9%. In the last 3 month period, MET beat the market returning +8.2%, while SPY returned +4.3%. However, in the most recent 2 weeks MET has underperformed the stock market by returning -0.2%, while SPY returned +1.7%.
MET support price is $93.22 and resistance is $95.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.